"META Medical Research Institute is a state-of-the-art research center focused on Phase I-IV clinical trials located within the greater Dayton, Ohio area. The institute is housed with several specialty clinics as well as an accredited ASC, Imaging Department and Toxicology Lab. At META Medical Research Institute, our advanced equipment and procedures deliver safe and effective care. We are dedicated to providing superior care, accurate data collection, rapid reporting, and open communication with sponsors, CROs, and regulatory agencies."

During the past decade, META Medical Research Institute conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 4 clinical trials were completed, i.e. on average, 17.4% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 4 clinical trials were completed. i.e. 23.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "META Medical Research Institute" #1 sponsor was "Eli Lilly and Company" with 10 trials, followed by "AEON Biopharma, Inc." with 2 trials sponsored, "Exact Sciences Corporation" with 2 trials sponsored, "Averitas Pharma, Inc." with 1 trials sponsored and "Guardant Health, Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "META Medical Research Institute" #1 collaborator was "PPD" with 2 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "MCRA" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "META Medical Research Institute" are "Colorectal Cancer" (3 trials), "Diabetic Peripheral Neuropathic Pain" (3 trials), "Chronic Low-back Pain" (2 trials), "Migraine" (2 trials) and "Osteoarthritis" (2 trials). Many other conditions were trialed in "META Medical Research Institute" in a lesser frequency.

Most popular intervention types in "META Medical Research Institute" are "Drug" (19 trials), "Other" (4 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "LY3556050" (3 trials), "ABP-450" (2 trials), "LY3526318" (2 trials) and "LY3857210" (2 trials). Other intervention names were less common.

The vast majority of trials in "META Medical Research Institute" are 23 trials for "All" genders.

Currently, there are NaN active trials in "META Medical Research Institute". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in META Medical Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in META Medical Research Institute, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".